Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 5 $ 28
Prepaid expenses 183 246
Total current assets 188 274
Deposits 12 12
Operating lease right-to-use asset 95 110
Total other assets 107 122
Total assets 295 396
Current Liabilities:    
Accounts payable 2,370 1,940
Accrued expenses 2,736 2,379
Accrued interest 2,651 2,029
Operating lease liability 105 120
Line of credit 31 31
Convertible debentures 13,257 13,207
Total current liabilities 21,150 19,706
Total liabilities 21,150 19,706
Commitments and contingencies
Stockholders' Deficit:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 70,599,433 and 69,784,699 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 71 70
Additional paid-in capital 548,280 548,118
Accumulated deficit (569,040) (567,332)
Noncontrolling interest (169) (169)
Total stockholders' deficit (20,855) (19,310)
Total liabilities and stockholders' deficit 295 396
Series C    
Stockholders' Deficit:    
Convertible preferred stock 1 1
Series J    
Stockholders' Deficit:    
Convertible preferred stock $ 2 $ 2